REVERSAL OF COGNITIVE DECLINE - A FUNCTIONAL MEDICINE APPROACH
Saturday, September 16: 1:30PM - 2:30PM
 
ABOUT THE LECTURE: 
 
Anecdotally, integrative and functional medicine providers have reported improvements in a multitude of cases of cognitive impairment, neuropsychiatric disease, and dementia. Of these reports, very few have published with systematic characterization of their approaches and methods. In 2014 Dr Dale Bredesen, the Director for Alzheimer’s Disease Programs and Neurodegenerative Disease Research at UCLA, published his first article on Reversal of Cognitive Decline in early stages of cognitive impairment. He went on to further clarify 3 major and 3 minor metabolic sub-types of cognitive decline and Alzheimer's. Effectively, this views Alzheimer's as a syndrome as opposed to a single disease entity. There have been nearly 300 hundred drug trials that have failed in their attempts to impact the disease course of Alzheimer's disease. Muti-domain trials - like the FINGER trial - have arrived. We believe a Functional Medicine approach is well suited to address the multi-system syndrome that is Alzheimer's type cognitive impairment. This presentation will outline the 3 major and 3 minor sub-types associated with Alzheimer's type cognitive decline. 1 inflammatory 1.5 glycotoxic 2 Atrophic 3 Toxic/Infectious 4 Vascular 5 Traumatic The purpose of this talk will be to outline the utility of these metabolic characterizations in terms of how they lead inform treatment strategies using a Functional Medicine approach. Case examples will be shared and their will be a cursory overview of key aspects of the medical history, genetics, neuroimaging, neuropsychological testing, lab interpretation with a focus on clinical utilization. 

Nate Bergman, DO
ABOUT DR. BERGMAN:
Nate Bergman DO, MBA has been passionate about proactive, preventive, and participatory medicine since his days as a research fellow at the NIH. He completed a fellowship in geriatric medicine with emphasis on Functional Medicine and the aging brain at the Cleveland Clinic. It was at that time that he first encountered Dr Dale Bredesen’s work on reversal of cognitive decline. He was then hired to serve at the Cleveland Clinic’s Center for Functional Medicine in order to further establish a program in brain health. Currently his group is involved in a prospective trial to test a Functional Medicine approach -based on Bredesen’s mechanistic theories- to positively impact those with early stages of cognitive decline. Nate remains curious about the incorporation of personalized dense dynamic data clouds, computational tools, and other technologic advances to assist the clinician at the bedside. He lives in suburban Cleveland with his wife and their five children. 


DISCLOSURE STATEMENT
Dr. Bergman has indicated that he has no financial relationships with any commercial supporters.


 


ACAM MEMBER SERVICES: Rachelle Morehead
1.800.532.3688  |  Rachelle.Morehead@acam.org

ACAM EXHIBITOR SERVICES: Jessica Ulmen
1.800.532.3688  |  Jessica.Ulmen@acam.org